Bridging preclinical research and clinical development
Expert consulting in translational medicine, biomarker strategies, and patient stratification for biotech, pharma, and academic organizations worldwide.
Bridging preclinical research and clinical development
Expert consulting in translational medicine, biomarker strategies, and patient stratification for biotech, pharma, and academic organizations worldwide.
Bridging preclinical research and clinical development
Expert consulting in translational medicine, biomarker strategies, and patient stratification for biotech, pharma, and academic organizations worldwide.
Decades of expertise in translational medicine
Bench2Bedside is a Swedish consulting company specializing in Translational Medicine, helping biotech, pharmaceutical, life science, and academic organizations successfully bridge the gap between preclinical research and clinical development. Bench2Bedside is founded on more than two decades of experience in translational medicine, across pharmaceutical and biotech environments seeking to derisk their clinical development pipeline by data driven decisions. We work with partners internationally to develop robust translational strategies and biomarker plans that maximize the probability of clinical success and enable informed decision-making throughout the drug development process.
Bench2Bedside is a Swedish consulting company specializing in Translational Medicine, helping biotech, pharmaceutical, life science, and academic organizations successfully bridge the gap between preclinical research and clinical development. Bench2Bedside is founded on more than two decades of experience in translational medicine, with a consistent focus on designing strategies that bridge preclinical research and clinical development. We work with partners internationally to develop robust translational strategies and biomarker plans that maximize the probability of clinical success and enable informed decision-making throughout the drug development process.
Our scientific focus areas
Translational plans and scientific guidance
Developing robust translational strategy frameworks and provide continuous scientific guidance throughout drug development, from target validation to early clinical studies including the direction of preclinical research.
Biomarker strategies and precision medicine
Expert biomarker discovery and implementation supporting pharmacodynamic assessment, ex vivo assessments, and precision medicine approaches to build data-driven translational plans for innovative therapies.
Patient stratification and enrichment
Advanced patient characterization, stratification, and subphenotyping to identify clinically meaningful patient populations and execute patient enrichment strategies that improve therapeutic response and optimize clinical trial design.
Translational plans and scientific guidance
Developing robust translational strategy frameworks and provide continuous scientific guidance throughout drug development, from target validation to early clinical studies including the direction of preclinical research.
Biomarker strategies and precision medicine
Expert biomarker discovery and implementation supporting pharmacodynamic assessment, ex vivo assessments, and precision medicine approaches to build data-driven translational plans for innovative therapies.
Patient stratification and enrichment
Advanced patient characterization, stratification, and subphenotyping to identify clinically meaningful patient populations and execute patient enrichment strategies that improve therapeutic response and optimize clinical trial design.
Prior leadership and industry experience
Prior leadership and industry experience
AstraZeneca
AM-Pharma
Novo Nordisk
Citryll
AstraZeneca
AM-Pharma
Novo Nordisk
Citryll
Integrating science with clinical outcomes
Bench2Bedside is founded on extensive experience across both innovative biotechnology companies and leading global pharmaceutical organizations. This broad industry expertise enables us to develop translational strategies, biomarker programs, patient stratification approaches, and support clinical development plans with informed decision-making for increased probability of clinical success. Our mission is to help clients accelerate the translation of innovative research into effective therapies through scientifically sound, data-driven decisions.
Integrating science and clinical expertise
Bench2Bedside is founded on extensive experience across both innovative biotechnology companies and leading global pharmaceutical organizations. This diverse industry expertise enables us to develop translational strategies, biomarker programs, patient stratification approaches, and clinical development plans that support informed decision-making and increase the probability of clinical success. Our mission is to help clients accelerate the translation of innovative research into effective therapies through scientifically sound, data-driven translational strategies.